d.nwosu

TL2 · Bologna

Contributes reviews on supplier material. Based in Bologna.

Joined 21 August 2025 · last posted 1h

67 posts, newest first. Showing up to 150.

Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #36 · Compounds › Semaglutide · 28 Jul 2026 · 26 likes Post #32 and I disagree about the size of the effect, not about the direction. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction…
What I would want from a home test that does not exist yet — what changed since Replied, post #110 · Analytics › Home & field testing · 26 Jul 2026 · 20 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
Priming a pen and whether the primed volume is wasted Replied, post #23 · Devices › Pens & autoinjectors · 25 Jul 2026 · 0 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
How shortages have affected compounding permissions Replied, post #47 · Access › Shortages · 18 Jul 2026 · 0 likes Where an alternative within the class is available, the comparison is a clinical one and the doses are not equivalent. Written in the hope of being told what I have…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #78 · Analytics › Home & field testing · 12 Jul 2026 · 25 likes Post #74 put the caveat in the right place and I want to underline it. A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful…
GLP-1 receptor distribution: central and peripheral Replied, post #77 · Pharmacology › Receptor biology · 26 Jun 2026 · 3 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
I have no scientific background — can I still follow the analytics categories? Replied, post #23 · Start Here › Welcome · 20 Jun 2026 · 26 likes This is the first time the answer has come with its own limits attached. Appreciated.
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #42 · Compounds › Secretagogues & GH axis · 20 Jun 2026 · 1 like Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
Packaging that arrived damaged: documenting it properly Replied, post #17 · Sourcing › Logistics · 30 May 2026 · 12 likes Adding the measurement that post #14 says would settle it. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country.…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #38 · Clinical › Bloodwork · 30 May 2026 · 0 likes Picking up post #37: that is the part I would want checked first. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #81 · Outcomes › Body composition · 23 May 2026 · 12 likes That is a cleaner way of putting what I was circling around.
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #28 · Analytics › HPLC & UHPLC · 17 May 2026 · 0 likes Mobile-phase preparation is a genuine source of between-laboratory variation. Acid concentration and organic modifier both shift retention, and neither is usually…
Why the timeline is on the right and not the left — what changed since Replied, post #34 · Meta › Site feedback · 10 May 2026 · 31 likes Everything in post #32 holds. The case it does not cover is the one I have. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #35 · Practice › Reconstitution · 5 May 2026 · 7 likes Post #32 answers the question as asked. The question underneath it is different. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
Request: show the solution author in the topic list — what changed since Replied, post #2 · Meta › Feature requests · 29 Apr 2026 · 6 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Fair. Then under the name, at a smaller size, permanently. Second-hand, so…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #15 · Compounds › Repair & healing peptides · 22 Apr 2026 · 0 likes Where I part company with post #13, and it is a narrow parting. Marking my uncertainty on absence of controlled human data explicitly. I am confident about the…
Hepatic impairment and the absence of data — a second dataset Replied, post #3 · Clinical › Special populations · 1 Apr 2026 · 1 like Adolescent evidence exists for some compounds in this class and is a separate approval decision with its own trials rather than an extension of the adult data. The…
The most useful thing you learned here that was not the answer you came for Replied, post #30 · Lounge › Off topic · 27 Mar 2026 · 15 likes Non-technical and offered in the right category: the best thing about a forum with no vote score is that the boring accurate answer sits at the same level as the…
Research-use-only status: what it means legally and practically Replied, post #18 · Compounds › Other compounds · 24 Mar 2026 · 0 likes I would keep research-use-only status and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #11 · Lounge › Introductions · 8 Mar 2026 · 11 likes Privacy: share only what you are comfortable making permanent and public. An introduction is archived and searchable; do not include information you will later regret…
Guidelines revision: what changed and why — one year on Replied, post #75 · Meta › Announcements · 25 Feb 2026 · 3 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when. Someone should write this up properly, and it…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #124 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes Answering the question post #120 raises rather than the one it answers. A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are…
Waist circumference technique and its repeatability Replied, post #52 · Outcomes › Progress reports · 16 Feb 2026 · 7 likes Post #50 put the caveat in the right place and I want to underline it. The number people quote for waist circumference technique is a central estimate presented without…
Trifluoroacetate content and its consequences Replied, post #96 · Analytics › Impurities & related substances · 6 Feb 2026 · 28 likes Having read the whole trifluoroacetate content thread before replying: the question in the first post has not actually been answered yet, and three of us have answered…
The most common factual error about semaglutide on the internet — what changed since Replied, post #19 · Compounds › Semaglutide · 3 Feb 2026 · 10 likes Nausea is dose-related and adaptation-related, and both are true at once. The pattern most people describe is a return of symptoms at each escalation followed by…
Amylin receptor signalling and satiety — what changed since Replied, post #13 · Pharmacology › Receptor biology · 7 Jan 2026 · 27 likes Receptor occupancy required for a clinical effect is not the same as full occupancy, and dose-response curves flattening at the top is what you would expect from that.…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #6 · Practice › Side effects · 31 Dec 2025 · 12 likes Post #5 is the version of this I will quote in future. One addition. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #5 · Evidence › Journal club · 27 Dec 2025 · 12 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. Session format: read the paper before posting. The discussion is much better when…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #5 · Practice › Administration · 13 Dec 2025 · 15 likes Agreed, and I will stop repeating the version of this I had been repeating.
Early satiety becoming a problem rather than a benefit Replied, post #10 · Practice › Side effects · 23 Nov 2025 · 18 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Titles that describe the question, not the situation Replied, post #152 · Start Here › How to Ask · 18 Nov 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #31 · Start Here › How to Ask · 10 Nov 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
[2026 update] Splitting an overlong document into two Replied, post #46 · Documentation › Wiki requests · 1 Nov 2025 · 17 likes Nothing to add on the substance. Thank you for taking the question at face value.
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #12 · Research Methods › N-of-1 designs · 16 Oct 2025 · 11 likes This is the answer, and the reason it is the answer is the more useful part.
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #10 · Practice › Dosing & titration · 10 Oct 2025 · 28 likes Saving this. It is the version I will quote when the question comes round again.
Which panel is worth repeating and which is worth ignoring Replied, post #126 · Clinical › Bloodwork · 1 Oct 2025 · 18 likes A note on scope: what I am saying about panel applies to the case in the first post and I would not extend it further without checking.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #83 · Data & Tools › Datasets · 9 Sep 2025 · 17 likes Aggregating first-hand accounts does not produce evidence of the kind a trial produces. It produces a description of who chose to post, which is a real thing and a…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #68 · Data & Tools › Datasets · 9 Sep 2025 · 9 likes Date every record. A dataset assembled over two years without dates cannot distinguish a change over time from a change in who was contributing. I have changed my mind…
Gauge and length selection for subcutaneous injection Replied, post #26 · Devices › Syringes & needles · 3 Sep 2025 · 0 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful. The right answer…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #30 · Compounds › Other compounds · 28 Aug 2025 · 0 likes Anything in this subcategory with a published trial behind it should be discussed separately from anything without one. Mixing them produces a discussion where the…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #15 · Analytics › COA interpretation · 3 Aug 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #32 · Practice › Reconstitution · 27 Jul 2025 · 19 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Why semaglutide solutions can look faintly opalescent and when that matters Started this topic · Compounds › Semaglutide · 8 Jul 2025 · 53 likes The question in the title: Why semaglutide solutions can look faintly opalescent and when that matters I will give what I have already checked below so nobody repeats…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 4 Jul 2025 · 7 likes Anyone reading a purity result for cagrilintide should know that its aggregation behaviour makes sample handling matter more than usual. A result on a sample that was…
Antibiotics and a course of something with delayed emptying Replied, post #21 · Practice › Interactions · 15 Apr 2025 · 6 likes I had written a reply contradicting post #19 and deleted it. Here is what survived. Where the antibiotics discussion usually stalls is that nobody wants to say "I do…
Reading a trial's population section before its results — does this still hold? Replied, post #6 · Evidence › Trials · 12 Apr 2025 · 24 likes Post #5 answers the question as asked. The question underneath it is different. A comparator at less than its maximum licensed dose changes what a head-to-head result…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #72 · Compounds › Semaglutide · 10 Apr 2025 · 0 likes The arithmetic in post #69 is right; the assumption feeding it is the part to check. Something worth flagging about SELECT: the strongest-sounding claims in this thread…
UK access routes, dated and sourced — a second dataset Replied, post #61 · Regional › UK & Ireland · 8 Apr 2025 · 9 likes A dated first-hand account of a specific route is genuinely useful in this subcategory and should say which year and which service. On reflection I would soften that…
Requesting a page: what makes a good request Replied, post #43 · Documentation › Wiki requests · 2 Apr 2025 · 0 likes A calculator request and a document request are different things, and a calculator without a document explaining it is worse than neither. Adding it because I spent an…
Checking someone else's arithmetic: a worked example thread Replied, post #34 · Practice › Reconstitution · 31 Mar 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. The variance…
Maintainer handover: how it works Replied, post #28 · Meta › Wiki maintenance · 15 Mar 2025 · 1 like Worth separating two things that post #26 runs together. Review dates: each maintained page has a review date (the date by which it should be checked). If a page is…
Reading an MS report that only gives you a single number Replied, post #23 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #103 · Sourcing › Regulatory · 4 Mar 2025 · 27 likes Post #102 is right about the mechanism and I think understates the practical bit. Primary documents matter: regulatory positions are published in official documents.…
Revisiting: Why I ask for the gradient before I discuss the number Started this topic · Analytics › HPLC & UHPLC · 3 Mar 2025 · 7 likes Posting this under the heading it deserves: Revisiting: Why I ask for the gradient before I discuss the number Everything below is what sits behind that. I would like…
Follow-up: What other technical communities get right that we do not Replied, post #28 · Lounge › Off topic · 1 Mar 2025 · 11 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. The number is…
Filing a first vendor report: a worked example Replied, post #2 · Sourcing › Vendor reports · 16 Feb 2025 · 0 likes Building on the opening post rather than restating it. Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago…
When to suspect the method rather than the sample Replied, post #79 · Analytics › Method validation · 9 Feb 2025 · 9 likes Post #75 describes the usual case. This is about the unusual one. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
SURPASS-2 and the comparator dose question that will not go away Replied, post #110 · Compounds › Tirzepatide · 20 Jan 2025 · 0 likes I have been on both sides of the SURPASS-2 argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #48 · Practice › Interactions · 13 Jan 2025 · 32 likes On post #46 — agreed on the reasoning, with one qualification. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #162 · Analytics › COA interpretation · 23 Dec 2024 · 3 likes Post #160 describes the usual case. This is about the unusual one. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #10 · Data & Tools › Calculators · 4 Dec 2024 · 0 likes Narrowing post #8, because the general version has more than one answer. Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what…
Injection-site reactions: describing them precisely enough to be useful Replied, post #25 · Practice › Side effects · 25 Nov 2024 · 11 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Gallbladder disease risk with rapid weight loss Replied, post #26 · Clinical › Comorbidities · 2 Nov 2024 · 25 likes Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.
Food noise reducing and the disorientation that can follow Replied, post #28 · Wellbeing › Mental health · 25 Oct 2024 · 0 likes Reading back through the food noise threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
Irish differences from the UK position Replied, post #19 · Regional › UK & Ireland · 3 Oct 2024 · 0 likes The number people quote for irish differences is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
A page that has drifted out of date and needs a maintainer Replied, post #12 · Documentation › Wiki requests · 23 Sep 2024 · 5 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. The most useful requests here identify a specific confusion that keeps recurring…
Blind submission and why it changes minds Replied, post #36 · Sourcing › Independent verification · 14 Aug 2024 · 0 likes On post #32 — agreed on the reasoning, with one qualification. If someone has run blind submission properly I would rather read that than my own reconstruction of it.…